Strategic Research Priorities Overview
Updated: September, 2016
The NIMH Strategic Plan for Research provides a framework to accelerate the pace of scientific progress by generating research that will have the greatest public health impact and continue to fuel the transformation of mental health care. The four Objectives of the Plan describe the breadth of mental health research that NIMH supports, ranging from understanding pathophysiology, to defining the trajectories of mental illnesses, to developing and testing new treatments and prevention strategies, to ensuring public health impact. To transform mental health care, NIMH recognizes that this continuum is bidirectional, and strives for innovation within each objective.
NIMH has highlighted several cross-cutting themes in the Strategic Plan which investigators are strongly encouraged to consider in proposed studies, including the Research Domain Criteria (RDoC) project, the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, and the Institute’s experimental therapeutics approach, in which ‘targets’ refer to hypothesized mechanisms of action and their ability to modify disease, behavior, or functional outcomes, and in which the underlying assumption is that modification of the target will result in improvement of symptoms, behavior, or functional outcomes. Equally important cross-cutting themes include the role of the environment, prevention through early intervention, consideration of sex as a biological variable, mental health disparities, and the importance of maintaining a global perspective on mental health.
NIMH strongly encourages investigators to use a standard set of common data elements, when available, to capture phenotypic and genomic data. In addition, NIMH expects investigators to share data and biospecimens through the appropriate databases and repositories, including, but not limited to: the NIMH Data Archive , which houses the National Database for Autism Research (NDAR), the National Database for Clinical Trials Related to Mental Illness (NDCT), the RDoC Database (RDoCdb), and the Adolescent Brain Cognitive Development Study (ABCD); the NIMH Repository and Genomics Resource (NRGR); and, the NIH Database of Genotypes and Phenotypes (dbGAP).
For the Institute to pursue its mission of transforming the understanding and treatment of mental illnesses most effectively, we request that all new and competing applications be targeted to the research priority areas within the four Objectives of the Strategic Plan. We invite the scientific community to apply for funding in these priority areas using the NIH Parent Announcements for Investigator-Initiated Applications ; NIMH-Sponsored Program Announcements and NIMH-Participating Program Announcements; and, NIMH-Sponsored Requests for Applications and NIMH-Participating Requests for Applications. By using the Plan to guide funding decisions, we hope to accelerate the translation of research findings into public health impact.
NIMH is also committed to supporting research that will address the public health challenge presented by HIV/AIDS. The Institute’s HIV/AIDS program will continue to be guided by the Trans-NIH Plan for HIV-Related Research coordinated by the NIH Office of AIDS Research .
Strategic Research Priorities are identified for each of the four Strategic Objectives outlined in the NIMH Strategic Plan for Research:
- Strategic Objective 1: Define the mechanisms of complex behaviors
- Strategic Objective 2: Chart mental illness trajectories to determine when, where, and how to intervene
- Strategic Objective 3: Strive for prevention and cures
- Strategic Objective 4: Strengthen the public health impact of NIMH-supported research
These Research Priorities are guided by workgroup reports including: the National Advisory Mental Health Council; the Interagency Autism Coordinating Committee Strategic Plan for Autism Spectrum Disorder Research ; the National Research Action Plan ; the Prioritized Research Agenda for Suicide Prevention ; and the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Working Group Interim Report .Questions? Please contact us .